APTEVO THERAPEUTICS INC COM SHS NEW
APTEVO THERAPEUTICS INC COM SHS NEW is a security (CUSIP 03835L702) tracked across SEC portfolio filings. 8 institutional managers reported $233K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $54K via N-PORT as of 2026-03-31.
Summary
- Issuer: APTEVO THERAPEUTICS INC
- Class: COM SHS NEW
- CUSIP: 03835L702
- Asset category: EC
- 13F holders: 8
- 13F value: $233K
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $54K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| VANGUARD GROUP INC | Valley Forge, PA | $159K | 16,856 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $57K | 13,337 |
| UBS Group AG | Zurich, V8 | $15K | 3,445 |
| OSAIC HOLDINGS, INC. | PHOENIX, AZ | $2K | 360 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $484 | 109 |
| GSA CAPITAL PARTNERS LLP | LONDON, X0 | $84 | 19,638 |
| CWM, LLC | OMAHA, NE | $21 | 5 |
| DANSKE BANK A/S | COPENHAGEN V, G7 | $4 | 1 |
Top fund holders (N-PORT)
More